Design, Synthesis, and Biological Evaluation of Novel Chimeric and Cyclic Peptide Ligands Targeting the Human Melanocortin-3 Receptor
PublisherThe University of Arizona.
RightsCopyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.
AbstractIn an effort to develop potent and selective agonists and antagonists for the human melanocortin-3 receptor, several new peptide design approaches were employed. This includes peptides featuring a chimeric fusion of the alpha-MSH and AgRP critical pharmacophores, as well as a variety of cyclic ligands which incorporated a variety of amino acid substitutions and dicarboxylic acid linkers for the construction of lactam bridges. Not only were potent and selective hMC3R superagonists obtained through this study (SRJ-(17-18)S), but several hMC1R (SRJ-(20-31)S) and hMC5R (SRJ-(02-03)L) selective peptides were also found. The active peptides identified in this study not only provide a basis for the rational design of melanocortin receptor ligands in the future, but show promise in therapeutic applications.
Degree ProgramHonors College